Vaxcyte, Inc. PCVX Lease Liability Payments - Remainder of Fiscal Year
Lease Liability Payments - Remainder of Fiscal Year at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s lease liability payments - remainder of fiscal year.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s lease liability payments - remainder of fiscal year?
- Vaxcyte, Inc. (PCVX) reported lease liability payments - remainder of fiscal year of $15.79M in Q1 2026.
- How has Vaxcyte, Inc.'s lease liability payments - remainder of fiscal year changed year-over-year?
- Vaxcyte, Inc.'s lease liability payments - remainder of fiscal year increased by 34.2% year-over-year, from $11.76M to $15.79M.
- What does lease liability payments - remainder of fiscal year mean?
- The contractual cash obligations for operating and finance leases due within the remaining months of the current fiscal year. This provides a short-term view of the company's fixed lease commitments. It is a critical component for assessing near-term liquidity and cash flow requirements.